"Receptors, Androgen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
Descriptor ID |
D011944
|
MeSH Number(s) |
D12.776.826.750.150
|
Concept/Terms |
Receptors, Androgen- Receptors, Androgen
- Androgen Receptor
- Receptor, Androgen
- Androgen Receptors
- Dihydrotestosterone Receptors
- Testosterone Receptor
- Receptors, Androgens
- Androgens Receptors
- Receptors, Dihydrotestosterone
- Receptors, Stanolone
- Stanolone Receptors
- Stanolone Receptor
- Receptor, Stanolone
- 5 alpha-Dihydrotestosterone Receptor
- 5 alpha Dihydrotestosterone Receptor
- Receptor, 5 alpha-Dihydrotestosterone
- alpha-Dihydrotestosterone Receptor, 5
- Receptor, Testosterone
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Androgen".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Androgen".
This graph shows the total number of publications written about "Receptors, Androgen" by people in this website by year, and whether "Receptors, Androgen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 2 | 2 | 4 |
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 2 | 1 | 3 |
1999 | 6 | 4 | 10 |
2000 | 7 | 3 | 10 |
2001 | 4 | 4 | 8 |
2002 | 5 | 1 | 6 |
2003 | 12 | 4 | 16 |
2004 | 7 | 5 | 12 |
2005 | 12 | 7 | 19 |
2006 | 8 | 3 | 11 |
2007 | 6 | 9 | 15 |
2008 | 9 | 5 | 14 |
2009 | 13 | 6 | 19 |
2010 | 8 | 7 | 15 |
2011 | 11 | 8 | 19 |
2012 | 10 | 5 | 15 |
2013 | 12 | 10 | 22 |
2014 | 16 | 14 | 30 |
2015 | 10 | 5 | 15 |
2016 | 17 | 8 | 25 |
2017 | 12 | 7 | 19 |
2018 | 10 | 5 | 15 |
2019 | 10 | 4 | 14 |
2020 | 11 | 2 | 13 |
2021 | 8 | 6 | 14 |
2022 | 6 | 7 | 13 |
2023 | 4 | 7 | 11 |
2024 | 5 | 4 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Androgen" by people in Profiles.
-
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells. Nat Commun. 2024 Sep 03; 15(1):7675.
-
Development of a Novel Amplifiable System to Quantify Hydrogen Peroxide in Living Cells. J Am Chem Soc. 2024 Aug 14; 146(32):22396-22404.
-
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. Nucleic Acids Res. 2024 Jul 22; 52(13):7740-7760.
-
Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness". Cell Rep Med. 2024 Jun 18; 5(6):101595.
-
Enzalutamide induces cytotoxicity in desmoplastic small round cell tumor independent of the androgen receptor. Commun Biol. 2024 Apr 04; 7(1):411.
-
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2024 Mar 15; 30(6):1152-1159.
-
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation. Nat Commun. 2024 Feb 07; 15(1):1148.
-
Regulation of androgen receptor stability by the ?1 Pix/STUB1 complex. FASEB J. 2024 02; 38(2):e23408.
-
Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. Cells. 2024 01 19; 13(2).
-
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer. Prostate. 2024 Mar; 84(4):349-357.